Publications
Below is a list of our favorite and recent publications.
For a full list follow link to Google Scholar.
-
High Temperature Cycles Result in Maternal Transmission and Dengue Infection Differences Between Wolbachia Strains in Aedes aegypti
Mancini MV, Ant TH, Herd CS, Martinez J, Murdochy SM, Gingell DD, Mararo E, Johnson PCD, Sinkins SP. mBio. 2021;12(6):e0025021. doi: 10.1128/mBio.00250-21
-
Establishment of Wolbachia Strain wAlbB in Malaysian Populations of Aedes aegypti for Dengue Control.
Nazni WA, Hoffmann AA, NoorAfizah A, Cheong YL, Mancini MV, Golding N, Kamarul GMR, […] Sinkins SP. Curr Biol. 2019;29(24):4241-4248.e5. doi: 10.1016/j.cub.2019.11.007
-
Wolbachia-Virus interactions and arbovirus control through population replacement in mosquitoes
Ant TH, Mancini MV*, McNamara CJ, Rainey SM, Sinkins SP. . Pathog Glob Health. 2023 May;117(3):245-258. doi: 10.1080/20477724.2022.2117939.
-
Wolbachia strain wAu efficiently blocks arbovirus transmission in Aedes albopictus
Mancini MV, Herd CS, Ant TH, Murdochy SM, Sinkins SP. . PLoS Negl Trop Dis. 2020;14(3):e0007926. doi: 10.1371/journal.pntd.0007926.
-
Wolbachia strain wAlbB maintains high density and dengue inhibition following introduction into a field population of Aedes aegypti.
Ahmad NA, Mancini MV, Ant TH, Martinez J, Kamarul GMR, Nazni WA, Hoffmann AA, Sinkins SP. Philos Trans R Soc Lond B Biol Sci. 2021;376(1818):20190809. doi: 10.1098/rstb.2019.0809.
-
Estimating bacteria diversity in different organs of nine species of mosquito by next generation sequencing
Mancini MV, Damiani C, Accoti A, Tallarita M, Nunzi E, Cappelli A, Bozic J, Catanzani R, Rossi P, Valzano M, Serrao A, Ricci I, Spaccapelo R, Favia G. . BMC Microbiol. 2018;18(1):126. doi: 10.1186/s12866-018-1266-9.
Publications
Collaborations
-
Evaluation of an Engineered Zika Virus-Like Particle Vaccine Candidate in a Mosquito-Mouse Transmission Model
Mancini MV, Tandavanitj R, Ant TH, Murdochy SM, Gingell DD, Setthapramote C, Natsrita P, Kohl A, Sinkins SP, Patel AH, De Lorenzo G. Evaluation of an Engineered Zika Virus-Like Particle Vaccine Candidate in a Mosquito-Mouse Transmission Model. mSphere. 2023 Apr 20;8(2):e0056422. doi: 10.1128/msphere.00564-22.
-
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses.
Dejnirattisai W, Huo J, Zhou D, Zahradník J, Supasa P, Liu C, Duyvesteyn HME, Ginn HM, Mentzer AJ, Tuekprakhon A, Nutalai R, Wang B, Dijokaite A, Khan S, Avinoam O, […], ISARIC4C Consortium; Paterson NG, Williams MA, Hall DR, Fry EE, Mongkolsapaya J, Ren J, Schreiber G, Stuart DI, Screaton GR. Cell. 2022 Feb 3;185(3):467-484.e15. doi: 10.1016/j.cell.2021.12.046. Epub 2022 Jan 4. PMID: 35081335; PMCID: PMC8723827.
-
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study.
Russell CD, Fairfield CJ, Drake TM, Turtle L, Seaton RA, Wootton DG, Sigfrid L, Harrison EM, Docherty AB, de Silva TI, Egan C, Pius R, Hardwick HE, Merson L, Girvan M, Dunning J, Nguyen-Van-Tam JS, Openshaw PJM, Baillie JK, Semple MG, Ho A; ISARIC4C investigators. Lancet Microbe. 2021 Aug;2(8):e354-e365. doi: 10.1016/S2666-5247(21)00090-2. Epub 2021 Jun 2. PMID: 34100002; PMCID: PMC8172149.